vimarsana.com
Home
Live Updates
Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simp
Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simp
Press Release: Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements
Nirsevimab: Sanofi, AstraZeneca and Sobi simplify contractual agreements Modification of existing collaboration agreement with AstraZeneca gives Sanofi full commercial control of nirsevimab and... | April 11, 2023
Related Keywords
Paris ,
France General ,
France ,
United States ,
Tarik Elgoutni ,
Evan Berland ,
Sandrine Guendoul ,
Felix Lauscher ,
Corentine Driancourt ,
Eva Schaefer Jansen ,
Nathalie Pham ,
European Union ,
Nasdaq ,
Euronext ,
Astrazeneca ,
Collaboration Agreement ,
Sanofi Stock Exchange ,
News ,
Information ,
Press Release ,
End ,
Gobi ,
Simplify ,
Contractual ,
Agreements ,
Modification ,
F ,
Xisting ,
Collaboration ,
Agreement ,
Ith ,
Lives ,
Sanofi ,
Bull ,
Commercial ,
Control ,
Irsevimab San Fr0000120578 ,